RMD
$246.44
Revenue | $1335.58Mn |
Net Profits | $348.54Mn |
Net Profit Margins | 26.1% |
Resmed Inc.’s revenue jumped 9.07% since last year same period to $1335.58Mn in the Q3 2025. On a quarterly growth basis, Resmed Inc. has generated -0.92% fall in its revenue since last 3-months.
Resmed Inc.’s net profit jumped 11.94% since last year same period to $348.54Mn in the Q3 2025. On a quarterly growth basis, Resmed Inc. has generated -8.21% fall in its net profits since last 3-months.
Resmed Inc.’s net profit margin jumped 2.63% since last year same period to 26.1% in the Q3 2025. On a quarterly growth basis, Resmed Inc. has generated -7.36% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 2.5 |
EPS Estimate Current Year | 2.5 |
Resmed Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.5 - a 0.81% jump from last quarter’s estimates.
Resmed Inc.’s earning per share (EPS) estimates for the current year stand at 2.5.
Earning Per Share (EPS) | 2.55 |
Dividend Per Share (DPS) | 0.53 |
Resmed Inc.’s earning per share (EPS) jumped 22.6% since last year same period to 2.55 in the Q2 2025. This indicates that the Resmed Inc. has generated 22.6% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Resmed Inc. declared 0.53 dividend per share during the earnings announcement for Q2 2025.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-04-23 | 2.36 | 2.37 | 0.42% |
2025-08-08 | 2.48 | 2.55 | 2.82% |